(Q34212215)

31 July 2017

1 reference

title

Polycystic ovary syndrome and hyperprolactinemia (English)

1 reference

polycystic ovary syndrome

31 July 2017

main subject

1 reference

1 reference

Bracero N

1

1 reference

31 July 2017

Zacur HA

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Obstetrics and Gynecology Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

77-84

1 reference

Prevalence of oligomenorrhea and amenorrhea in a college population

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Effects of dopamine and metoclopramide in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Adrenal androgen production in hyperprolactinemic states

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Hyperprolactinemic anovulatory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Adrenocortical Function in Hyperprolactinemic Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Effect of androgens on prolactin (PRL) release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

The epidemiology of secondary amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: comparison with acromegaly and normal lactation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Incidence and significance of hyperprolactinaemia in women with amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Factors involved in the control of the activity of the tubero-infundibular dopamine neurons during pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Therapy-orientated diagnosis of secondary amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Inhibition of Gonadotropin and Prolactin Release by Dopamine: Effect of Endogenous Estradiol Levels*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Androgen and cortisol responses to ACTH stimulation in women with hyperprolactinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

IN VITRO PRODUCTION OF ANDROGENS BY A VIRILIZING ADRENAL ADENOMA AND ASSOCIATED POLYCYSTIC OVARIES

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Galactorrhea and amenorrhea with polycystic ovaries. Del Castillo syndrome or polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Prolactin release in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Studies of prolactin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Adult-onset amenorrhea: a study of 262 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Raised serum prolactin levels associated with hirsutism and amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Menstrual disorders in college students

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Pathogenesis of polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Radiographic abnormalities in patients with Stein-Leventhal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Small-cystic degeneration of ovaries as an incidental finding in gynecological laparotomies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Multifactorial regulation of prolactin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

Plasma dopamine-β-hydroxylase activity and norepinephrine levels during the human menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970186-8

7 January 2021

10.1016/S0889-8545(05)70186-8

Identifiers

DOI

1 reference

31 July 2017

1 reference